GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (MEX:ZTS) » Definitions » Net Change in Cash

Zoetis (MEX:ZTS) Net Change in Cash : MXN-813 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zoetis Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Zoetis's Net Change in Cash for the three months ended in Sep. 2024 was MXN2,757 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-813 Mil.

Zoetis Net Change in Cash Historical Data

The historical data trend for Zoetis's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Net Change in Cash Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,261.52 33,219.64 -2,441.17 1,871.62 -26,140.34

Zoetis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 644.50 4,871.61 -1,095.35 -7,346.36 2,756.64

Zoetis Net Change in Cash Calculation

Zoetis's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=39940.406+-13188.991+-52772.937+-118.82
=-26,140

Zoetis's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=18725.475+-3504.873+-12365.508+-98.452
=2,757

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-813 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Zoetis's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (MEX:ZTS) » Definitions » Net Change in Cash
Comparable Companies
VTRS NBIX CTLT ITCI ELAN LNTH ALKS PRGO PBH ALVO XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB
Traded in Other Exchanges
ZTS:USA 1ZTS:Italy 0M3Q:UK ZOE:Germany Z1TS34:Brazil ZOTS:Austria
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Website
https://www.zoetis.com
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.